Suppr超能文献

1,4-二羟基-2-萘甲酸[校正后]异戊烯基转移酶抑制剂的发现:针对多重耐药革兰氏阳性病原体的新型药物先导物

Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.

作者信息

Kurosu Michio, Narayanasamy Prabagaran, Biswas Kallolmay, Dhiman Rakesh, Crick Dean C

机构信息

Department of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, 1682 Campus Delivery, Fort Collins, Colorado 80523-1682, USA.

出版信息

J Med Chem. 2007 Aug 23;50(17):3973-5. doi: 10.1021/jm070638m. Epub 2007 Jul 21.

Abstract

Since utilization of menaquinone in the electron transport system is a characteristic of Gram-positive organisms, the 1,4-dihydroxy-2-naphthoate prenyltransferase (MenA) inhibitors 1a and 2a act as selective antibacterial agents against organisms such as methicillin-resistant Stapylococcus aureus (MRSA), Staphylococcus epidermidis (MRSE), and Mycobacterium spp. Growth of drug-resistant Gram-positive organisms was sensitive to the MenA inhibitors, indicating that menaquinone synthesis is a valid new drug target in Gram-positive organisms.

摘要

由于甲萘醌在电子传递系统中的利用是革兰氏阳性菌的一个特性,1,4 - 二羟基 - 2 - 萘甲酸异戊烯基转移酶(MenA)抑制剂1a和2a可作为针对耐甲氧西林金黄色葡萄球菌(MRSA)、表皮葡萄球菌(MRSE)和分枝杆菌属等细菌的选择性抗菌剂。耐药革兰氏阳性菌的生长对MenA抑制剂敏感,这表明甲萘醌合成是革兰氏阳性菌中一个有效的新药物靶点。

相似文献

引用本文的文献

本文引用的文献

2
Overview of nosocomial infections caused by gram-negative bacilli.革兰氏阴性杆菌引起的医院感染概述。
Clin Infect Dis. 2005 Sep 15;41(6):848-54. doi: 10.1086/432803. Epub 2005 Aug 16.
7
Ubiquinone and vitamin K in bacteria.细菌中的泛醌和维生素K。
Biochem J. 1962 Jun;83(3):606-14. doi: 10.1042/bj0830606.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验